CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

<p>Background & Aims</p> <p>End points to determine the efficacy and safety of medical therapies for Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in current outcome measures, harmonizing end points in a core outcome set for randomized c...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Ma, C, Hanzel, J, Panaccione, R, Sandborn, WJ, D'Haens, GR, Ahuja, V, Atreya, R, Bernstein, CN, Bossuyt, P, Bressler, B, Bryant, RV, Cohen, B, Colombel, J-F, Danese, S, Dignass, A, Dubinsky, MC, Fleshner, PR, Gearry, RB, Hanauer, SB, Hart, A, Kotze, PG, Kucharzik, T, Lakatos, PL, Leong, RW, Magro, F, Panés, J, Peyrin-Biroulet, L, Ran, Z, Regueiro, M, Singh, S, Spinelli, A, Steinhart, AH, Travis, SP, van der Woude, CJ, Yacyshyn, B, Yamamoto, T, Allez, M, Bemelman, WA, Lightner, AL, Louis, E, Rubin, DT, Scherl, EJ, Siegel, CA, Silverberg, MS, Vermeire, S, Parker, CE, McFarlane, SC, Guizzetti, L, Smith, MI, Casteele, NV, Feagan, BG, Jairath, V
مؤلفون آخرون:	CORE-IBD Collaborators
التنسيق:	Journal article
اللغة:	English
منشور في:	Elsevier 2022

CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease

مواد مشابهة